
This review establishes a theoretical framework for the “cytokine-epigenetic axis,” systematically elucidating the dual molecular mechanisms by which cytokines influence epigenetic modifications through both metabolic reprogramming that affects epigenetic substrates and direct regulation of epigenetic enzymes via signaling pathways such as JAK-STAT and NF-κB. It reveals how this axis drives chronic progression and therapeutic resistance in autoimmune diseases, neuropsychiatric disorders, metabolic diseases, and cancer by establishing persistent functional reprogramming. Furthermore, it outlines novel therapeutic strategies, including combined interventions and epigenetic memory reprogramming, offering innovative disease-modifying approaches to overcome refractory chronic conditions.
View this paper